Sally Biga

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

M. McGuckin, S. Bowler, R. Lourie, 2013, JAMA.

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.

M. McGuckin, D. Venter, S. Taylor, 2016, Annals of the American Thoracic Society.